CatalystEU/UK

ELI LILLY OBESITY DRUG DATA ADDS PRESSURE ON NOVO NORDISK

Eli Lilly obesity drug data intensifies competitive pressure on Novo Nordisk.

What changed

Eli Lilly obesity drug data intensifies competitive pressure on Novo Nordisk.

Why it matters

Eli Lilly obesity drug data intensifies competitive pressure on Novo Nordisk. — impact context not separately stored; see What changed.

Sources